Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Nucleic Acids Res ; 49(D1): D1268-D1275, 2021 01 08.
Article in English | MEDLINE | ID: mdl-33270889

ABSTRACT

DNA methylation is an important epigenetic regulator in gene expression and has several roles in cancer and disease progression. MethHC version 2.0 (MethHC 2.0) is an integrated and web-based resource focusing on the aberrant methylomes of human diseases, specifically cancer. This paper presents an updated implementation of MethHC 2.0 by incorporating additional DNA methylomes and transcriptomes from several public repositories, including 33 human cancers, over 50 118 microarray and RNA sequencing data from TCGA and GEO, and accumulating up to 3586 manually curated data from >7000 collected published literature with experimental evidence. MethHC 2.0 has also been equipped with enhanced data annotation functionality and a user-friendly web interface for data presentation, search, and visualization. Provided features include clinical-pathological data, mutation and copy number variation, multiplicity of information (gene regions, enhancer regions, and CGI regions), and circulating tumor DNA methylation profiles, available for research such as biomarker panel design, cancer comparison, diagnosis, prognosis, therapy study and identifying potential epigenetic biomarkers. MethHC 2.0 is now available at http://awi.cuhk.edu.cn/∼MethHC.


Subject(s)
Biomarkers, Tumor/genetics , DNA Methylation , Databases, Genetic , Epigenesis, Genetic , Gene Expression Regulation, Neoplastic , Neoplasms/genetics , Biomarkers, Tumor/metabolism , Circulating Tumor DNA/blood , Circulating Tumor DNA/genetics , DNA Copy Number Variations , Disease Progression , Enhancer Elements, Genetic , High-Throughput Nucleotide Sequencing , Humans , Internet , Microarray Analysis , Molecular Sequence Annotation , Mutation , Neoplasms/classification , Neoplasms/diagnosis , Neoplasms/metabolism , Software , Transcriptome
2.
Nucleic Acids Res ; 48(D1): D148-D154, 2020 01 08.
Article in English | MEDLINE | ID: mdl-31647101

ABSTRACT

MicroRNAs (miRNAs) are small non-coding RNAs (typically consisting of 18-25 nucleotides) that negatively control expression of target genes at the post-transcriptional level. Owing to the biological significance of miRNAs, miRTarBase was developed to provide comprehensive information on experimentally validated miRNA-target interactions (MTIs). To date, the database has accumulated >13,404 validated MTIs from 11,021 articles from manual curations. In this update, a text-mining system was incorporated to enhance the recognition of MTI-related articles by adopting a scoring system. In addition, a variety of biological databases were integrated to provide information on the regulatory network of miRNAs and its expression in blood. Not only targets of miRNAs but also regulators of miRNAs are provided to users for investigating the up- and downstream regulations of miRNAs. Moreover, the number of MTIs with high-throughput experimental evidence increased remarkably (validated by CLIP-seq technology). In conclusion, these improvements promote the miRTarBase as one of the most comprehensively annotated and experimentally validated miRNA-target interaction databases. The updated version of miRTarBase is now available at http://miRTarBase.cuhk.edu.cn/.


Subject(s)
Databases, Nucleic Acid , MicroRNAs/metabolism , Circulating MicroRNA/metabolism , Data Mining , Gene Expression Regulation , RNA, Messenger/metabolism , User-Computer Interface
SELECTION OF CITATIONS
SEARCH DETAIL
...